title: Optimal use of prostate specific antigen for prostate cancer screening.
authors.affiliation: Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio, USA.
authors.forename: Ranko
authors.initials: R
authors.lastname: Miocinović
authors.forename: Uros
authors.initials: U
authors.lastname: Bumbasirević
authors.forename: Miroslav L
authors.initials: ML
authors.lastname: Djordjević
authors.forename: Nebojsa
authors.initials: N
authors.lastname: Bojanić
authors.forename: Bogomir
authors.initials: B
authors.lastname: Milojević
authors.forename: Cane
authors.initials: C
authors.lastname: Tulić
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Stephenson
mesh_terms: D006801:Humans; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000175:diagnosis*; D018570:Risk Assessment
chemical_list: D017430:Prostate-Specific Antigen